Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods
Authors
Keywords
Metformin, Oral Glucose Tolerance Test, Aripiprazole, Orlistat, Sibutramine
Journal
Child and Adolescent Psychiatry and Mental Health
Volume 7, Issue 1, Pages 31
Publisher
Springer Nature
Online
2013-08-16
DOI
10.1186/1753-2000-7-31
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metformin Inhibits Nuclear Receptor TR4-Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity
- (2011) E. Kim et al. DIABETES
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A systematic review of metformin to limit weight-gain with atypical antipsychotics
- (2011) Y. J. Lee et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Developments in Pediatric Psychopharmacology
- (2011) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
- (2011) Zaina P. Qureshi et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
- (2010) Brian L. Strom et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic–Induced Weight Gain
- (2010) Lara K Ellinger et al. ANNALS OF PHARMACOTHERAPY
- Management of antipsychotic-related weight gain
- (2010) Lawrence Maayan et al. Expert Review of Neurotherapeutics
- Questionable Antipsychotic Prescribing Remains Common, Despite Serious Risks
- (2010) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis
- (2010) Linda Björkhem-Bergman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Weight Management Interventions in Children: A Targeted Systematic Review for the USPSTF
- (2010) E. P. Whitlock et al. PEDIATRICS
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine
- (2009) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
- (2009) CHRISTOPH U. CORRELL et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?
- (2009) David B. Allison et al. PSYCHIATRY RESEARCH
- Pharmacotherapy in pediatric obesity: Current agents and future directions
- (2009) Abigail B. Wald et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
- (2009) L. B. Dixon et al. SCHIZOPHRENIA BULLETIN
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Topiramate in the prevention of pediatric migraine: literature review
- (2008) Diana Ferraro et al. JOURNAL OF HEADACHE AND PAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started